The Chinese Authorities First Approved the I.I.-Made COVID-19 Drug.
5 Articles
5 Articles
The Chinese authorities allowed the sale of a new Mprosevir drug, created using artificial intelligence technologies, to be made available to the University of Shihu (CPC). The Chinese authorities approved the release of an innovative coronavirus drug, which was developed using artificial intelligence technologies, is being transferred to RIA News. The University of Shiha reported: "The first innovation drug developed with artificial intelligenc…
The authorities classified it as a class 1 drug, a category reserved for compounds that have not previously been placed on the market either in China or abroad.
The Chinese authorities approved the Mprosevir, a product from COVID-19, which used artificial intelligence to develop it. This is the first innovative IE-made drug in the PRC to report to the University of Sihu. The drug received conditional approval from the Chinese NMPA regulator.
The authorities classified it as a class 1 drug, a category reserved for compounds that have not previously been marketed in China or abroad, and that also present a new chemical structure, an original mechanism of action and a clear clinical value. The post China approves the marketing of its first drug created with the help of IA first appeared on Cubadebate.
It is noted that Mprosevir has been developed by specialists from the University of Sihu and university-related scientific and pharmaceutical organizations and is intended to treat adult patients with light and medium forms of COVID-19. The substance in use is the 3CLpro virus enzyme inhibitor required by SARS-CoV-2 for reproduction.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
